Post-marketing surveillance of administration of botulinum toxin type B(NerBloc )-Investigation of the clinical condition and safety in patients with cervical dystonia (Study NB01S)
Phase of Trial: Phase IV
Latest Information Update: 26 Mar 2018
At a glance
- Drugs Botulinum toxin B (Primary)
- Indications Torticollis
- Focus Therapeutic Use
- Sponsors Eisai Co Ltd
- 22 Mar 2018 Planned End Date changed from 1 Dec 2017 to 31 Aug 2019.
- 22 Mar 2018 Planned primary completion date changed from 1 Dec 2017 to 31 Jan 2019.
- 30 Jun 2014 New trial record